Day: April 8, 2024

BERKELEY HEIGHTS, N.J., April 08, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing therapeutic products for life-threatening diseases and conditions, today announced that it has entered into a 5-year commercial supply contract with Florida-based dialysis provider, ARC Dialysis, LLC for the supply of DefenCath® (taurolidine and heparin). CorMedix received NDA approval of DefenCath® under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD) on November 15, 2023, and expects to begin commercialization of the product in the inpatient setting on April 15th. CorMedix is committed to building meaningful long-term relationships with dialysis providers that are dedicated to innovation and infection reduction. ARC Dialysis, a Miami-based medium-sized dialysis...

Profitable Acquisition Expected to Contribute More than $8 Million of Annualized Revenue and Over $1 Million of Adjusted EBITDA MIAMI, April 08, 2024 (GLOBE NEWSWIRE) — Smart for Life, Inc. (Nasdaq: SMFL) (“Smart for Life” or the “Company”), a global leader in the Health & Wellness sector marketing and manufacturing nutritional foods and supplements worldwide, today announced that it has executed a definitive agreement to acquire Purely Optimal Nutrition, a premier eCommerce nutraceuticals company with operations in North America. A.J. Cervantes, Jr., Smart for Life’s founder and Chairman, stated, “We are very excited to have Purely Optimal join forces under the Smart for Life umbrella. Purely Optimal’s product line is designed to yield optimal results with carefully sourced and nourishing ingredients from all around the world....

– In preclinical studies, CHS-1000 shows a high affinity for human ILT4, reverses ILT4-mediated immunosuppressive functions, leading to activation of immune cells and increased cytokine secretion –– Mechanism may enhance antitumor responses with immunotherapy –– First novel immuno-oncology product candidate discovered and developed by Coherus –– The CHS-1000 IND submission is planned for Q2 2024 – REDWOOD CITY, Calif., April 08, 2024 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (Coherus, Nasdaq: CHRS), today presented preclinical data for its immuno-oncology pipeline candidate, CHS-1000, a novel ILT4 monoclonal antibody, at the 2024 AACR Annual Meeting being held in San Diego, California. Data presented show CHS-1000 is a potent monoclonal antibody that binds selectively to human ILT4 (also known as LILRB2) with high affinity,...

Subsidiary NetNut’s revenues surged approximately 140% in the first quarter of 2024 compared to the equivalent period in 2023  Tel Aviv, Israel, April 08, 2024 (GLOBE NEWSWIRE) — Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a global provider of internet access and web data collection solutions, today provided preliminary key financial metrics guidance for the three months ended on March 31, 2024. Based on a preliminary, unaudited review, Alarum anticipates reporting strong performance for the first quarter of 2024, highlighting accelerated operating and business growth:Revenue for the first quarter of 2024 is estimated at more than $8.3 million, representing the highest quarterly revenue achievement to date and an estimated increase of close to 50% compared to the same period in 2023. In the first...

Bids in the nominal amount of 37,000 m.kr. were submitted for RIKV 24 0717, and bids in the nominal amount of 26,000 m.kr. were accepted at the price of 97.482 and simple interest of 9.489%. Bids in the nominal amount of 25,045 were submitted for RIKV 24 1016, and bids in the nominal amount of 16,895 were accepted at the price of 95.249 and simple interest of 9.501%.

TOKYO, April 08, 2024 (GLOBE NEWSWIRE) — Lead Real Estate Co., Ltd (Nasdaq: LRE) (“LRE” or the “Company”), a Japanese real estate developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo, today announced that Booking.com had awarded the Company the Traveller Review Award 2024 for the ENT TERRACE AKIHABARA Hotel, with a rating of 9.5 out of 10. Booking.com’s Traveller Awards is an esteemed list of international properties based on over 308 million customer reviews. Review scores for this award are based on the average of all customer reviews published on the Bookings.com website and app between December 1, 2020 and November 30, 2023. The final review score was calculated on December 1, 2023, based on reviews received in the previous three years.   “Booking.com’s...

San Antonio, TX, April 08, 2024 (GLOBE NEWSWIRE) — Clearday (OTCQX CLRD) is pleased to announce that Clearday Club Leon Valley is hosting a watch event for the Solar Eclipse. The Clubs’ Solar Eclipse event will highlight engagement activities involving astronomy with a focus on the Stars, the Sun and the Moon! We are planning the day’s menu around the sun as a theme – such as Sun Chips, raisins and Sunkissed products. The highlight of the day will be the 1 ½ hours outdoors in a secure environment so all of our members are safe and not at risk to a “silver alert.” All participants will get Solar Eclipse glasses to protect their vision The Clearday Club is located at 6812 Bandera Road, San Antonio, Texas. “The eclipse is a very unique event. It is not just local, but it touches us all globally. In a profound way its universal nature...

Nasdaq OMX Copenhagen A/S Charlottenlund, April 8, 2024 Announcement no. 255 Annual results for 2023 Following stock exchange announcement no. 253 of March 27, 2024, the board of directors has adopted the annual report for 2023 today.The group’s result of continuing activities before tax amounted to EUR -4.8 million (EUR -3.8 million in 2022). The management considers the result as expected, given the current economic conditions and market conditions in Germany.The group’s result of continuing activities before value adjustments and tax amounted to EUR 0.3 million in 2023 (EUR 0.9 million in 2022), which is in accordance with the latest expectations range of EUR 0.2 – 0.6 million, announced in the interim report for the first quarter of 2023.The group’s revenue of continuing activities amounted to EUR 4.5 million...